Chemoinformaics analysis of 2,6,10-trimethyltetradecane
| Molecular Weight | 240.475 | nRot | 11 |
| Heavy Atom Molecular Weight | 204.187 | nRig | 0 |
| Exact Molecular Weight | 240.282 | nRing | 0 |
| Solubility: LogS | -7.07 | nHRing | 0 |
| Solubility: LogP | 7.898 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 52.3945 |
| nHD | 0 | BPOL | 36.1155 |
| QED | 0.389 |
| Synth | 2.842 |
| Natural Product Likeliness | 0.58 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.036 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.463 |
| MDCK | 0.00000837 |
| BBB | 0.36 |
| PPB | 0.98309 |
| VDSS | 2.883 |
| FU | 0.0227934 |
| CYP1A2-inh | 0.332 |
| CYP1A2-sub | 0.195 |
| CYP2c19-inh | 0.375 |
| CYP2c19-sub | 0.643 |
| CYP2c9-inh | 0.353 |
| CYP2c9-sub | 0.943 |
| CYP2d6-inh | 0.073 |
| CYP2d6-sub | 0.033 |
| CYP3a4-inh | 0.169 |
| CYP3a4-sub | 0.112 |
| CL | 6.487 |
| T12 | 0.046 |
| hERG | 0.047 |
| Ames | 0.004 |
| ROA | 0.018 |
| SkinSen | 0.932 |
| Carcinogencity | 0.038 |
| EI | 0.949 |
| Respiratory | 0.209 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.659526 |